Enables researchers to study the expression level of genes to compare primary tumor with normal tissue samples. UALCAN is an interactive web resource that provides critical information and graphic ability to make stage, grade, race and other sub status specific expression features from transcriptome sequencing data. This portal can aid in the identification of candidate biomarkers of specific cancer subclasses, with diagnostic, prognostic or therapeutic implications. It can also be used as a platform for in silico validation of target genes.
Molecular and Cellular Pathology, Department of Pathology, University of Alabama, Birmingham, AL, USA; Comprehensive Cancer Center, University of Alabama, Birmingham, AL, USA; Department of Medicine, Dan L. Duncan Comprehensive Cancer Center, and Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA
UALCAN funding source(s)
Supported by The University of Alabama Birmingham and Breast Cancer Research Foundation of Alabama, NIH/NCI [R01CA157845, R01CA154980], and NIH CA125123.